Comparing the effects of Atorvastatin and Rosuvastatin in preventing acute kidney injury due to contrast media

Not Applicable

• Conditions: Other and unspecified drugs and medicament; Contrast Induced Nephropathy.

• Registration Number: IRCT2017101236737N1
• Lead Sponsor: Vice chancellor for research, Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

occurrence of first episode of ST elevation Myocardial Infarction (STEMI); performing primary per-cutaneous coronary intervention for patients.
Exclusion criteria: patients under-dialysis; acute kidney injury before angiography; cardiogenic shock; consumption of drugs like N-acetyl cysteine, vitamin C, consumption of venous contrast for other cause, manitol, diuretics, Theophylline and Dopamin in recent two weeks before PCI; having intra-aortic balloon pump; patients with previous cardiac surgery; patients who were candidate for CABG after angioplasty; patients who received G2b3a drugs during PPCI

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
evel of serum creatinine. Timepoint: 24 hours after intervention and 72 hours after intervention. Method of measurement: mg/ deciliter.

Secondary Outcome Measures

Name	Time	Method
Glumerolar filtration rate. Timepoint: 24hours after intervention and 72hours after intervention. Method of measurement: ml/min/1.73 m2.